Acomplia
AttorneyOne.com is a free nationwide legal referral service. We are not a law firm. We help consumers find the best representation for their legal needs.
If you or a loved one are in need of legal assistance concerning Acomplia you should get a lawyer on your side immediately. You will pay no attorney fees unless you win your case.
Email up to 10 Acomplia law firms in one click; by filling out the simple Free Case Evaluation form.
For additional info on Acomplia use the related topic links on the far right.
Acomplia In The News
Some Weight-Loss Drugs Might Disrupt Brain Growth in KidsTitle: Some Weight-Loss Drugs Might Disrupt Brain Growth in Kids Category: Health News Created: 5/8/2008 2:00:00 AM Last Editorial Review: 5/8/2008
Some Weight-Loss Drugs Might Disrupt Brain Growth in KidsWEDNESDAY, May 7 (HealthDay News) -- A new class of weight-loss drugs that suppresses appetite by blocking cannabinoid receptors in the brain should be used with caution in children, U.S. scientists report.
Some Weight-Loss Drugs Might Disrupt Brain Growth in KidsWEDNESDAY, May 7 (HealthDay News) -- A new class of weight-loss drugs that suppresses appetite by blocking cannabinoid receptors in the brain should be used with caution in children,...
Study suggests caution on a new anti-obesity drug in childrenA new class of anti-obesity drugs that suppresses appetite by blocking cannabinoid receptors in the brain could also suppress the adaptive rewiring of the brain necessary for neural development in children, studies with mice have indicated. One such drug, rimonabant (trade name Acomplia) has been developed by Sanofi-Aventis and is awaiting approval for use in the U.S., and other pharmaceutical ...
Study suggests caution on a new anti-obesity drug in childrenA new class of anti-obesity drugs that suppresses appetite by blocking cannabinoid receptors in the brain could also suppress the adaptive rewiring of the brain necessary for neural development in children, studies with mice have indicated.
UPI NewsTrack Health and Science NewsRobots may someday operate without doctors … ESA, NASA to share space achievement award … Method found to make tumors easier to kill … Caution urged for kids' anti-obesity drugs ... Health/Science news from UPI.
UPI NewsTrack Health and Science NewsRobots may someday operate without doctorsDURHAM, N.C., May 8 (UPI) -- U.S. engineers say the world is moving closer to the day when robots will perform surgery with minimal or no guidance from a doctor.Duke University researchers say their feasibility studies may represent the first concrete steps toward achieving such a space age vision of the future.For their experiments, the engineers used a .
Caution urged for kids' anti-obesity drugsU.S. medical scientists are urging caution in giving children anti-obesity drugs, saying the medications might interfere with neural development.Researchers from the Massachusetts Institute of Technology's Picower Institute for Learning and Memory say the new class of drugs -- such as rimonabant (trade name Acomplia) -- work by blocking the same receptor cells in the brain that bind to compounds .
Weight-loss drugs may harm developing brain: studyA drug from a new class of weight-loss treatments disrupted wiring needed for brain development in young mice, U.S. researchers said on Wednesday, raising concerns about using such medications in children.
Caution Recommended For New Anti-Obesity Drug In ChildrenA new class of anti-obesity drugs that suppresses appetite by blocking cannabinoid receptors in the brain could also suppress the adaptive rewiring of the brain necessary for neural development in children, studies with mice have indicated. One such drug, rimonabant (trade name Acomplia) has been developed by Sanofi-Aventis and is awaiting approval for use in the U.S.
